Neuromuscular and neurological Flashcards
Levodopa is for
Parkinson’s disease
What does Levodopa do?
It’s the precursor of dopamine. Increase brain dopamine (DA) by crossing the BBB and being converted to DA to replenish depleted striata DA. It can be converted in the peripheral tissue so is usually administered with peripheral inhibitors to avoid AEs
Levodopa works with
Benserazide, carbidopa and entacapone (inhibit levodopa conversion to dopamine in peripheral tissues because it can’t cross the BBB as dopamine).
Amantadine (stimulate dopamine release)
Selegiline (inhibit the breakdown of dopamine)
Benserazide and carbidopa are
Inhibitors of decarboxylase and can’t cross the BBB. Given as fixed-dose combos
AEs of Levodopa:
Nausea, vomiting chemoreceptor zone (CTZ), orthostatic hypotension, involuntary movements (head, lips, tongue), agitation and confusion (due to the disease itself) and depression (may require antidepressants).
Entacapone is for
Parkinson’s disease
What does entacapone do
Inhibits catechol-O-methyltransferase (COMT- metabolises catecholamines like DA and levodopa)
Can entacapone cross the BBB
No
What does entacapone affect and do
Mainly the peripheral COMT and prolongs the clinical response to levodopa
AEs of entacapone:
Nausea and vomiting, diarrhoea, dyskinesia and drug-drug interactions.
What is amantadine for
Parkinson’s disease
What does amantadine do
It’s an antiviral used against some strains of bacteria. It increases DA release, blocks cholinergic receptors, and acts as an N-methyl-D-aspartate antagonist in the glutamatergic pathway from the subthalamic nucleus to globus pallidus.
AEs of amantadine
Nightmares, insomnia, hallucinations, dizziness, orthostatic hypotension and ankle oedema.
What is selegiline for
Parkinson’s disease
What is selegiline
A MAO type B inhibitor (MAO-B). Inhibition of MAO-B activity increase DA levels and may also block DA re-uptake. MAO-B is an enzyme that degrades DA particularly in the SN (serotoninergic neurons)